BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16542836)

  • 21. Dermatomyositis and polymyositis: new treatment targets on the horizon.
    Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
    Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies in inflammatory myopathies.
    Garlepp MJ; Mastaglia FL
    Am J Med Sci; 2000 Apr; 319(4):227-33. PubMed ID: 10768607
    [No Abstract]   [Full Text] [Related]  

  • 23. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features.
    Mantegazza R; Bernasconi P; Confalonieri P; Cornelio F
    J Neurol; 1997 May; 244(5):277-87. PubMed ID: 9178151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of autoimmune inflammatory myopathies.
    Mastaglia FL
    Curr Opin Neurol; 2000 Oct; 13(5):507-9. PubMed ID: 11073355
    [No Abstract]   [Full Text] [Related]  

  • 28. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
    Krajnc I
    Adv Exp Med Biol; 1999; 455():181-6. PubMed ID: 10599341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent clinical trials in idiopathic inflammatory myopathies.
    Leclair V; Lundberg IE
    Curr Opin Rheumatol; 2017 Nov; 29(6):652-659. PubMed ID: 28763333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory treatment for dermatomyositis.
    Callen JP
    Curr Allergy Asthma Rep; 2008 Jul; 8(4):348-53. PubMed ID: 18606089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory myopathies from internist's perspective].
    Genth E
    Internist (Berl); 2000 May; 41(5):445-54. PubMed ID: 10867900
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
    Quick A; Tandan R
    Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM; Reed AM
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation".
    Dalakas MC
    Ann Neurol; 2008 Jul; 64(1):1-3. PubMed ID: 18626972
    [No Abstract]   [Full Text] [Related]  

  • 39. New Autoantibodies in Inflammatory Myopathies: Diagnostic Value and Relationship with Clinical Phenotypes.
    Selva-O'Callaghan A; Cervera R
    Isr Med Assoc J; 2015 Feb; 17(2):108-9. PubMed ID: 26223087
    [No Abstract]   [Full Text] [Related]  

  • 40. Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies.
    Kissel JT
    Semin Neurol; 2002 Mar; 22(1):41-51. PubMed ID: 12170392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.